Sanofi
SNY
$50.05
-$0.53-1.05%
NASDAQ
| 06/30/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | 11.34B | 11.26B | 13.37B | 10.06B | |
| Total Other Revenue | 840.98M | 912.47M | 901.49M | 784.85M | |
| Total Revenue | 12.18B | 12.17B | 14.27B | 10.85B | |
| Cost of Revenue | 3.40B | 3.81B | 4.03B | 3.19B | |
| Gross Profit | 8.79B | 8.36B | 10.24B | 7.66B | |
| SG&A Expenses | 2.63B | 2.82B | 2.45B | 2.38B | |
| Depreciation & Amortization | 429.00M | 479.69M | 440.85M | 441.13M | |
| Other Operating Expenses | 1.37B | 949.78M | 1.12B | 983.80M | |
| Total Operating Expenses | 9.99B | 10.47B | 10.03B | 8.77B | |
| Operating Income | 2.19B | 1.70B | 4.24B | 2.07B | |
| Income Before Tax | 1.66B | 1.14B | 3.83B | 1.44B | |
| Income Tax Expenses | 261.03M | 202.53M | 751.97M | 295.03M | |
| Earnings from Continuing Operations | 1.40B | 938.05M | 3.08B | 1.14B | |
| Earnings from Discontinued Operations | 3.07B | -197.20M | 43.98M | 46.98M | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -4.54M | -12.79M | -31.88M | -4.19M | |
| Net Income | 4.47B | 728.06M | 3.09B | 1.19B | |
| EBIT | 2.19B | 1.70B | 4.24B | 2.07B | |
| EBITDA | 3.05B | 2.59B | 5.05B | 3.01B | |
| EPS Basic | 3.67 | 0.58 | 2.47 | 0.95 | |
| Normalized Basic EPS | 1.14 | 0.78 | -- | -- | |
| EPS Diluted | 3.67 | 0.58 | 2.47 | 0.94 | |
| Normalized Diluted EPS | 1.14 | 0.78 | -- | -- | |
| Average Basic Shares Outstanding | 1.22B | 1.25B | 1.25B | 1.25B | |
| Average Diluted Shares Outstanding | 1.22B | 1.25B | 1.25B | 1.25B | |
| Dividend Per Share | -- | 4.18 | -- | -- | |
| Payout Ratio | -- | -- | -- | 209.44% | |